These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6850416)

  • 1. The in vitro inhibition of hepatic ferrochelatase by divalent lead and other soft metal ions.
    Gaertner RR; Hollebone BR
    Can J Biochem Cell Biol; 1983 Apr; 61(4):214-22. PubMed ID: 6850416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal inhibition of ferrochelatase activity in human lymphocytes.
    Rossi E; Attwood PV; Garcia-Webb P; Costin KA
    Clin Chim Acta; 1990 Apr; 188(1):1-13. PubMed ID: 2347080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal inhibition of ferrochelatase.
    Dailey HA
    Ann N Y Acad Sci; 1987; 514():81-6. PubMed ID: 3442391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of zinc protoporphyrin in cultured hepatocytes: effects of ferrochelatase inhibition, iron chelation or lead.
    Jacobs JM; Sinclair PR; Sinclair JF; Gorman N; Walton HS; Wood SG; Nichols C
    Toxicology; 1998 Feb; 125(2-3):95-105. PubMed ID: 9570325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme.
    Dailey HA; Fleming JE
    J Biol Chem; 1983 Oct; 258(19):11453-9. PubMed ID: 6688622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible role of copper in the regulation of heme biosynthesis through ferrochelatase.
    Wagner GS; Tephly TR
    Adv Exp Med Biol; 1975; 58(00):343-54. PubMed ID: 1155252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin IX.
    Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
    Biochem Biophys Res Commun; 1981 Nov; 103(2):581-6. PubMed ID: 7332558
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetic studies of human liver ferrochelatase. Role of endogenous metals.
    Camadro JM; Ibraham NG; Levere RD
    J Biol Chem; 1984 May; 259(9):5678-82. PubMed ID: 6425295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX.
    Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1436-42. PubMed ID: 6894236
    [No Abstract]   [Full Text] [Related]  

  • 10. Metal ion selectivity and substrate inhibition in the metal ion chelation catalyzed by human ferrochelatase.
    Davidson RE; Chesters CJ; Reid JD
    J Biol Chem; 2009 Dec; 284(49):33795-9. PubMed ID: 19767646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.
    De Matteis F; Gibbs AH; Harvey C
    Biochem J; 1985 Mar; 226(2):537-44. PubMed ID: 3838893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    Tephly TR; Gibbs AH; Ingall G; De Matteis F
    Int J Biochem; 1980; 12(5-6):993-8. PubMed ID: 7450161
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal ion substrate inhibition of ferrochelatase.
    Hunter GA; Sampson MP; Ferreira GC
    J Biol Chem; 2008 Aug; 283(35):23685-91. PubMed ID: 18593702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of chironomidae ferrochelatase: copper activation of the purified ferrochelatase.
    Leung YK; Wong KF; Lee HK; Ho JW
    Mol Cell Biochem; 2004 Jul; 262(1-2):225-31. PubMed ID: 15532727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements in dihydropyridines for ferrochelatase inhibition and delta-aminolevulinic acid synthetase induction.
    Cole SP; Marks GS
    Int J Biochem; 1980; 12(5-6):989-92. PubMed ID: 7450160
    [No Abstract]   [Full Text] [Related]  

  • 17. Site-directed mutagenesis of human ferrochelatase: identification of histidine-263 as a binding site for metal ions.
    Kohno H; Okuda M; Furukawa T; Tokunaga R; Taketani S
    Biochim Biophys Acta; 1994 Nov; 1209(1):95-100. PubMed ID: 7947988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the substrate-metal binding site of ferrochelatase: an X-ray absorption spectroscopic study.
    Ferreira GC; Franco R; Mangravita A; George GN
    Biochemistry; 2002 Apr; 41(15):4809-18. PubMed ID: 11939775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
    McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
    Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipids on the activity of ferrochelatase.
    Simpson DM; Poulson R
    Biochim Biophys Acta; 1977 Jun; 482(2):461-9. PubMed ID: 406931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.